India approves $1.9 billion Agila acquisition US generics company Mylan wins go-ahead to buy Bangalore-based injectables business from India’s Strides Arcolab. September 05, 2013
Mylan agrees to pay $1.6 billion for Agila Specialities Mylan plans to buy the injectable medicine unit of India’s Strides Arcolab. March 01, 2013